首页 > 最新文献

HCA healthcare journal of medicine最新文献

英文 中文
Plasma Cell-Rich Lymphoid Neoplasm in an Endocervical Polyp of the Uterine Cervix in a Perimenopausal 52-Year-Old Woman. 52岁围绝经期妇女宫颈息肉中富含浆细胞的淋巴样肿瘤。
Pub Date : 2025-02-01 eCollection Date: 2025-01-01 DOI: 10.36518/2689-0216.1809
Anjali Patel, Jacqueline Haas, Angela Kueck

Background: The adaptive immune system consists of T and B lymphocytes, with some B lymphocytes further differentiating into plasma cells that secrete antibodies and make up the humoral immune system. Extramedullary plasmacytoma, mucosa-associated lymphoid tissue (MALT) lymphoma, and plasmablastic lymphoma are all plasma cell-rich lymphoid neoplasms that rarely present in the female genital tract. To date, few case reports of these malignancies arising within the uterine cervix exist.

Case presentation: This case report describes a 52-year-old perimenopausal woman who presented to her primary obstetrician-gynecologist for an annual exam with the complaint of light spotting following an endometrial ablation that occurred several years prior. During the pelvic exam, we discovered and subsequently biopsied an endocervical polyp. The pathological examination of this polyp demonstrated atypical plasma cells and lymphocytes, indicating a leading diagnosis of extramedullary plasmacytoma. The results of further workup, which included a complete blood count, comprehensive metabolic panel, bone marrow biopsy, and a whole-body PET-CT scan, all came back negative for systemic disease. A surgical resection, including a total hysterectomy and bilateral salpingectomy, was performed. Bilateral ovarian conservation was performed due to this patient's perimenopausal status as well as the positive cardiovascular, cognitive, and bone benefits. A secondary pathology review of the endocervical polyp broadened the differential diagnosis to include MALT and plasmablastic lymphoma.

Conclusion: Extramedullary plasmacytomas, MALT lymphomas, and plasmablastic lymphomas carry a risk of progression to multiple myeloma and systemic disease, requiring close surveillance. A total hysterectomy is the most definitive treatment for confined neoplasms. Removing the bilateral ovaries in premenopausal or perimenopausal women places the patient in surgical menopause, which is vastly detrimental to the overall health of the patient. Therefore, thoughtful consideration regarding the benefits and risks of a bilateral oophorectomy versus ovarian conservation is imperative. Additionally, plasma cell-rich lymphomas are not estrogen-driven cancers like other gynecologic cancers, which support ovarian conservation.

背景:适应性免疫系统由T淋巴细胞和B淋巴细胞组成,其中一些B淋巴细胞进一步分化为分泌抗体的浆细胞,构成体液免疫系统。髓外浆细胞瘤、粘膜相关淋巴组织(MALT)淋巴瘤和浆母细胞淋巴瘤都是富含浆细胞的淋巴样肿瘤,很少出现在女性生殖道。迄今为止,很少有病例报告这些恶性肿瘤发生在子宫颈存在。病例介绍:本病例报告描述了一位52岁的围绝经期妇女,她在几年前子宫内膜消融后,以轻度斑点的主诉向她的初级妇产科医生进行年度检查。在盆腔检查中,我们发现并活检了一个宫颈息肉。病理检查显示不典型浆细胞和淋巴细胞,提示髓外浆细胞瘤的主要诊断。进一步的检查结果包括全血细胞计数、综合代谢组、骨髓活检和全身PET-CT扫描,结果均为全身性疾病阴性。手术切除,包括全子宫切除术和双侧输卵管切除术。由于该患者的围绝经期状态以及积极的心血管、认知和骨骼益处,我们进行了双侧卵巢保护。宫颈内息肉的二次病理检查扩大了鉴别诊断,包括MALT和浆母细胞淋巴瘤。结论:髓外浆细胞瘤、MALT淋巴瘤和浆母细胞淋巴瘤有进展为多发性骨髓瘤和全身性疾病的风险,需要密切监测。全子宫切除术是局限性肿瘤最明确的治疗方法。在绝经前或围绝经期妇女中,切除双侧卵巢使患者处于手术绝经期,这对患者的整体健康极为不利。因此,对双侧卵巢切除与卵巢保留的利弊进行深思熟虑是必要的。此外,富浆细胞淋巴瘤不像其他妇科癌症那样是雌激素驱动的癌症,这支持卵巢保护。
{"title":"Plasma Cell-Rich Lymphoid Neoplasm in an Endocervical Polyp of the Uterine Cervix in a Perimenopausal 52-Year-Old Woman.","authors":"Anjali Patel, Jacqueline Haas, Angela Kueck","doi":"10.36518/2689-0216.1809","DOIUrl":"10.36518/2689-0216.1809","url":null,"abstract":"<p><strong>Background: </strong>The adaptive immune system consists of T and B lymphocytes, with some B lymphocytes further differentiating into plasma cells that secrete antibodies and make up the humoral immune system. Extramedullary plasmacytoma, mucosa-associated lymphoid tissue (MALT) lymphoma, and plasmablastic lymphoma are all plasma cell-rich lymphoid neoplasms that rarely present in the female genital tract. To date, few case reports of these malignancies arising within the uterine cervix exist.</p><p><strong>Case presentation: </strong>This case report describes a 52-year-old perimenopausal woman who presented to her primary obstetrician-gynecologist for an annual exam with the complaint of light spotting following an endometrial ablation that occurred several years prior. During the pelvic exam, we discovered and subsequently biopsied an endocervical polyp. The pathological examination of this polyp demonstrated atypical plasma cells and lymphocytes, indicating a leading diagnosis of extramedullary plasmacytoma. The results of further workup, which included a complete blood count, comprehensive metabolic panel, bone marrow biopsy, and a whole-body PET-CT scan, all came back negative for systemic disease. A surgical resection, including a total hysterectomy and bilateral salpingectomy, was performed. Bilateral ovarian conservation was performed due to this patient's perimenopausal status as well as the positive cardiovascular, cognitive, and bone benefits. A secondary pathology review of the endocervical polyp broadened the differential diagnosis to include MALT and plasmablastic lymphoma.</p><p><strong>Conclusion: </strong>Extramedullary plasmacytomas, MALT lymphomas, and plasmablastic lymphomas carry a risk of progression to multiple myeloma and systemic disease, requiring close surveillance. A total hysterectomy is the most definitive treatment for confined neoplasms. Removing the bilateral ovaries in premenopausal or perimenopausal women places the patient in surgical menopause, which is vastly detrimental to the overall health of the patient. Therefore, thoughtful consideration regarding the benefits and risks of a bilateral oophorectomy versus ovarian conservation is imperative. Additionally, plasma cell-rich lymphomas are not estrogen-driven cancers like other gynecologic cancers, which support ovarian conservation.</p>","PeriodicalId":73198,"journal":{"name":"HCA healthcare journal of medicine","volume":"6 1","pages":"89-94"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892398/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143607020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical Considerations of Percutaneous Endoscopic Gastrostomy Tube Placement in a Patient With Creutzfeldt-Jakob Disease and Advanced Dementia. 克雅氏病合并晚期痴呆患者经皮内镜胃造口管置入的伦理考虑
Pub Date : 2025-02-01 eCollection Date: 2025-01-01 DOI: 10.36518/2689-0216.1836
Toni Habib, Niamh Siobhán Mulrooney, Yisroel Grabie, Mohammad Maruf, Sophia Kasapira

Background: Creutzfeldt-Jakob disease (CJD) is a rapidly progressive neurodegenerative condition that is not easily diagnosed and has no curative treatments available, essentially requiring palliative measures, including tube feeding. Nonetheless, data shows that the endoscope used for percutaneous endoscopic gastrostomy (PEG) tube insertion can be a vector for CJD transmission.

Case presentation: We discuss the case of an elderly patient diagnosed with CJD, requiring tube feeding. Multiple specialists were consulted, and they were unable to reach an agreement on the best approach. Eventually, the hospital ethics committee intervened, and the family agreed to comfort measures only. This case report sheds light on the ethical challenges surrounding the use of endoscopically assisted PEG tube placement for patients with confirmed or suspected CJD.

Conclusion: Ethical consideration for patients with dementia, especially with CJD, includes evaluating harm and benefit, considering legal and societal responsibilities, respecting autonomy, and managing transmission risks. Based on our findings, we encourage interdisciplinary collaboration when navigating complex medical decision-making for patients with human prion diseases and advanced dementia.

背景:克雅氏病(Creutzfeldt-Jakob disease, CJD)是一种快速进展的神经退行性疾病,不易诊断,也没有治愈的治疗方法,基本上需要姑息性措施,包括管饲。然而,有资料显示,用于经皮内镜胃造口术(PEG)插管的内窥镜可能是CJD传播的载体。病例介绍:我们讨论的情况下,老年患者诊断克雅氏病,需要管饲。咨询了多位专家,但他们无法就最佳办法达成一致意见。最终,医院伦理委员会介入,家属只同意采取安慰措施。本病例报告阐明了在确诊或疑似CJD患者中使用内窥镜辅助PEG管置入的伦理挑战。结论:痴呆患者,特别是CJD患者的伦理考虑包括评估危害和利益、考虑法律和社会责任、尊重自主权和管理传播风险。基于我们的发现,我们鼓励跨学科合作,为人类朊病毒疾病和晚期痴呆患者制定复杂的医疗决策。
{"title":"Ethical Considerations of Percutaneous Endoscopic Gastrostomy Tube Placement in a Patient With Creutzfeldt-Jakob Disease and Advanced Dementia.","authors":"Toni Habib, Niamh Siobhán Mulrooney, Yisroel Grabie, Mohammad Maruf, Sophia Kasapira","doi":"10.36518/2689-0216.1836","DOIUrl":"10.36518/2689-0216.1836","url":null,"abstract":"<p><strong>Background: </strong>Creutzfeldt-Jakob disease (CJD) is a rapidly progressive neurodegenerative condition that is not easily diagnosed and has no curative treatments available, essentially requiring palliative measures, including tube feeding. Nonetheless, data shows that the endoscope used for percutaneous endoscopic gastrostomy (PEG) tube insertion can be a vector for CJD transmission.</p><p><strong>Case presentation: </strong>We discuss the case of an elderly patient diagnosed with CJD, requiring tube feeding. Multiple specialists were consulted, and they were unable to reach an agreement on the best approach. Eventually, the hospital ethics committee intervened, and the family agreed to comfort measures only. This case report sheds light on the ethical challenges surrounding the use of endoscopically assisted PEG tube placement for patients with confirmed or suspected CJD.</p><p><strong>Conclusion: </strong>Ethical consideration for patients with dementia, especially with CJD, includes evaluating harm and benefit, considering legal and societal responsibilities, respecting autonomy, and managing transmission risks. Based on our findings, we encourage interdisciplinary collaboration when navigating complex medical decision-making for patients with human prion diseases and advanced dementia.</p>","PeriodicalId":73198,"journal":{"name":"HCA healthcare journal of medicine","volume":"6 1","pages":"99-104"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143606734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors Associated With Worse Outcomes in Trauma Patients Aged 55 and Older. 55岁及以上创伤患者预后较差的相关危险因素
Pub Date : 2025-02-01 eCollection Date: 2025-01-01 DOI: 10.36518/2689-0216.1830
Hector Mendez, Ilko Luque, Nicole Yordán López, Carlos Parra, Kelvin Chan, Mariel A Javier, Marcela Ramirez, Orlando Morejón

Background: Prior studies have shown an increase in mortality in trauma patients after 55 years of age. However, it is less certain which pre-existing comorbidities (PECs) are associated with poorer outcomes. The purpose of this study was to identify the risk factors associated with poor outcomes and death in patients 55 years old and older admitted for trauma.

Methods: Trauma patients (age ≥ 55) were studied retrospectively from the local trauma registry at HCA Florida Kendall Hospital, a level 1 trauma center (2020-22). We collected the subject's age, gender, PECs, and outcome data. Then we performed multiple logistic regression to assess which PECs were associated with in-hospital mortality, acute kidney injury (AKI), ventilator-associated pneumonia (VAP), and unplanned intensive care unit (ICU) admission.

Results: We identified 5168 trauma patients 55 years old and older, of which 54.9% were female. Chronic renal failure (CRF) increased the odds of in-hospital mortality (adjusted odds ratio [aOR] = 2.30, P < .001), unplanned ICU admission (aOR = 1.73, P = .033), and AKI (aOR = 2.97, P < .001). Congestive heart failure (CHF) increased the odds of in-hospital mortality (aOR = 1.75, P < .001), unplanned ICU admission (aOR = 2.64, P < .001), and VAP (aOR = 2.42, P = .047). Cirrhosis increased the odds of in-hospital mortality (aOR = 3.78, P = .007), unplanned ICU admission (aOR = 3.11, P = .007), and AKI (aOR = 3.78, P = .007).

Conclusion: Our analysis showed an association between certain comorbidities and poor outcomes in geriatric trauma patients 55 years old and older; namely, CRF, CHF, and cirrhosis were linked to increased in-hospital mortality, unplanned ICU admission, and the development of complications. Identifying these risk factors can aid in developing protocols to improve monitoring and complication-reduction strategies.

背景:先前的研究表明55岁以后的创伤患者死亡率增加。然而,尚不确定哪些预先存在的合并症(PECs)与较差的预后有关。本研究的目的是确定55岁及以上因创伤入院的患者预后不良和死亡的相关危险因素。方法:回顾性研究来自HCA佛罗里达肯德尔医院(一级创伤中心,2020- 2022年)当地创伤登记处的创伤患者(年龄≥55岁)。我们收集了受试者的年龄、性别、PECs和结局数据。然后,我们采用多元logistic回归来评估哪些PECs与住院死亡率、急性肾损伤(AKI)、呼吸机相关性肺炎(VAP)和计划外重症监护病房(ICU)住院有关。结果:5168例55岁及以上的创伤患者,其中54.9%为女性。慢性肾功能衰竭(CRF)增加了住院死亡率(校正优势比[aOR] = 2.30, P < 0.001)、非计划住院(aOR = 1.73, P = 0.033)和AKI (aOR = 2.97, P < 0.001)。充血性心力衰竭(CHF)增加了住院死亡率(aOR = 1.75, P < 0.001)、非计划入住ICU (aOR = 2.64, P < 0.001)和VAP (aOR = 2.42, P = 0.047)的几率。肝硬化增加住院死亡率(aOR = 3.78, P = .007)、计划外ICU入院(aOR = 3.11, P = .007)和AKI (aOR = 3.78, P = .007)的几率。结论:我们的分析显示,55岁及以上的老年创伤患者的某些合并症与不良预后之间存在关联;也就是说,慢性肾功能衰竭、慢性心力衰竭和肝硬化与住院死亡率增加、计划外ICU住院和并发症的发生有关。识别这些风险因素有助于制定方案,以改善监测和减少并发症的策略。
{"title":"Risk Factors Associated With Worse Outcomes in Trauma Patients Aged 55 and Older.","authors":"Hector Mendez, Ilko Luque, Nicole Yordán López, Carlos Parra, Kelvin Chan, Mariel A Javier, Marcela Ramirez, Orlando Morejón","doi":"10.36518/2689-0216.1830","DOIUrl":"10.36518/2689-0216.1830","url":null,"abstract":"<p><strong>Background: </strong>Prior studies have shown an increase in mortality in trauma patients after 55 years of age. However, it is less certain which pre-existing comorbidities (PECs) are associated with poorer outcomes. The purpose of this study was to identify the risk factors associated with poor outcomes and death in patients 55 years old and older admitted for trauma.</p><p><strong>Methods: </strong>Trauma patients (age ≥ 55) were studied retrospectively from the local trauma registry at HCA Florida Kendall Hospital, a level 1 trauma center (2020-22). We collected the subject's age, gender, PECs, and outcome data. Then we performed multiple logistic regression to assess which PECs were associated with in-hospital mortality, acute kidney injury (AKI), ventilator-associated pneumonia (VAP), and unplanned intensive care unit (ICU) admission.</p><p><strong>Results: </strong>We identified 5168 trauma patients 55 years old and older, of which 54.9% were female. Chronic renal failure (CRF) increased the odds of in-hospital mortality (adjusted odds ratio [aOR] = 2.30, <i>P</i> < .001), unplanned ICU admission (aOR = 1.73, <i>P</i> = .033), and AKI (aOR = 2.97, <i>P</i> < .001). Congestive heart failure (CHF) increased the odds of in-hospital mortality (aOR = 1.75, <i>P</i> < .001), unplanned ICU admission (aOR = 2.64, <i>P</i> < .001), and VAP (aOR = 2.42, P = .047). Cirrhosis increased the odds of in-hospital mortality (aOR = 3.78, <i>P</i> = .007), unplanned ICU admission (aOR = 3.11, <i>P</i> = .007), and AKI (aOR = 3.78, <i>P</i> = .007).</p><p><strong>Conclusion: </strong>Our analysis showed an association between certain comorbidities and poor outcomes in geriatric trauma patients 55 years old and older; namely, CRF, CHF, and cirrhosis were linked to increased in-hospital mortality, unplanned ICU admission, and the development of complications. Identifying these risk factors can aid in developing protocols to improve monitoring and complication-reduction strategies.</p>","PeriodicalId":73198,"journal":{"name":"HCA healthcare journal of medicine","volume":"6 1","pages":"57-63"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892407/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143607200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Exacerbation of Idiopathic Pulmonary Fibrosis in the Setting of Acute Eosinophilic Pneumonia. 急性嗜酸性粒细胞肺炎导致特发性肺纤维化急性加重。
Pub Date : 2025-02-01 eCollection Date: 2025-01-01 DOI: 10.36518/2689-0216.1802
Duncan A McKinney, Noah R Kosnik, Shahzeib Syed, Gretchen Junko

Description Idiopathic pulmonary fibrosis (IPF) is a progressive disease characterized by gradual destruction and replacement of pulmonary parenchyma with fibrous tissue, which occurs in conjunction with chronic inflammation. It is often considered a prototypical interstitial lung disease and is both the most prevalent and perhaps the most dangerous in that family. Although the disease is uncommon in the general population, its prevalence increases with age and is typically diagnosed around the age of 65. This does not preclude the development of IPF in younger individuals, and the mean survival is 2 to 5 years post-diagnosis regardless of age. Contemporary studies have provided insight into how altered pulmonary parenchyma results in increased susceptibility to opportunistic infections. It has also been demonstrated that pulmonary insults that cause inflammation, such as pneumonia, may accelerate the progression of IPF. Eosinophilic pneumonias are a collection of pulmonary diseases in which eosinophil-mediated inflammation results in respiratory compromise. Early recognition and appropriate intervention are imperative to minimize the risk of residual pulmonary function deficits, a risk that is increased in individuals with separate pulmonary risk factors. While prompt diagnosis and pharmacologic interventions are associated with improved outcomes, patients with IPF remain at risk of deterioration to the point of requiring lung transplantation. Early screening for those at risk continues to be a topic of interest. Despite the prevalence of IPF, its pathogenesis remains poorly understood and few management options are available. In this article, we document a unique case of previously undiagnosed IPF in a young individual that acutely worsened in the setting of acute eosinophilic pneumonia and the involvement of an opportunistic organism, Aspergillus niger. The case section will serve as a transition into a discussion of each of the major pathologic factors at play, supported by a review of recent literature.

特发性肺纤维化(IPF)是一种进行性疾病,其特征是肺实质逐渐被纤维组织破坏和取代,并伴有慢性炎症。它通常被认为是一种典型的间质性肺疾病,在该家族中是最普遍的,也许也是最危险的。虽然这种疾病在一般人群中并不常见,但其患病率随着年龄的增长而增加,通常在65岁左右被诊断出来。这并不排除IPF在年轻个体中的发展,无论年龄大小,诊断后的平均生存期为2至5年。当代研究已经深入了解了肺实质改变如何导致对机会性感染的易感性增加。也有研究表明,引起炎症的肺部损伤,如肺炎,可能会加速IPF的进展。嗜酸性粒细胞肺炎是一系列肺部疾病,其中嗜酸性粒细胞介导的炎症导致呼吸系统损伤。早期识别和适当的干预对于将残余肺功能缺陷的风险降至最低至关重要,这种风险在具有单独肺危险因素的个体中会增加。虽然及时诊断和药物干预与改善预后相关,但IPF患者仍有恶化到需要肺移植的风险。对那些有风险的人进行早期筛查仍然是一个有趣的话题。尽管IPF普遍存在,但其发病机制仍然知之甚少,并且很少有可用的治疗方案。在这篇文章中,我们记录了一个独特的病例,以前未确诊的IPF在一个年轻人的急性嗜酸性粒细胞性肺炎和机会性生物,黑曲霉的参与下急剧恶化。病例部分将作为一个过渡,讨论每个主要的病理因素在发挥作用,支持最近的文献回顾。
{"title":"Acute Exacerbation of Idiopathic Pulmonary Fibrosis in the Setting of Acute Eosinophilic Pneumonia.","authors":"Duncan A McKinney, Noah R Kosnik, Shahzeib Syed, Gretchen Junko","doi":"10.36518/2689-0216.1802","DOIUrl":"10.36518/2689-0216.1802","url":null,"abstract":"<p><p>Description Idiopathic pulmonary fibrosis (IPF) is a progressive disease characterized by gradual destruction and replacement of pulmonary parenchyma with fibrous tissue, which occurs in conjunction with chronic inflammation. It is often considered a prototypical interstitial lung disease and is both the most prevalent and perhaps the most dangerous in that family. Although the disease is uncommon in the general population, its prevalence increases with age and is typically diagnosed around the age of 65. This does not preclude the development of IPF in younger individuals, and the mean survival is 2 to 5 years post-diagnosis regardless of age. Contemporary studies have provided insight into how altered pulmonary parenchyma results in increased susceptibility to opportunistic infections. It has also been demonstrated that pulmonary insults that cause inflammation, such as pneumonia, may accelerate the progression of IPF. Eosinophilic pneumonias are a collection of pulmonary diseases in which eosinophil-mediated inflammation results in respiratory compromise. Early recognition and appropriate intervention are imperative to minimize the risk of residual pulmonary function deficits, a risk that is increased in individuals with separate pulmonary risk factors. While prompt diagnosis and pharmacologic interventions are associated with improved outcomes, patients with IPF remain at risk of deterioration to the point of requiring lung transplantation. Early screening for those at risk continues to be a topic of interest. Despite the prevalence of IPF, its pathogenesis remains poorly understood and few management options are available. In this article, we document a unique case of previously undiagnosed IPF in a young individual that acutely worsened in the setting of acute eosinophilic pneumonia and the involvement of an opportunistic organism, <i>Aspergillus niger</i>. The case section will serve as a transition into a discussion of each of the major pathologic factors at play, supported by a review of recent literature.</p>","PeriodicalId":73198,"journal":{"name":"HCA healthcare journal of medicine","volume":"6 1","pages":"11-21"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892399/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143607455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A New Paradigm in Hospital Medicine: Evaluating the Effects of Geographical Cohorting on Health Care Delivery. 医院医学的新范例:评估地域队列对医疗服务的影响。
Pub Date : 2025-02-01 eCollection Date: 2025-01-01 DOI: 10.36518/2689-0216.1865
Vasu Gupta, Bhupinder Singh, Kanishk Aggarwal, Ayushi Garg, Rhea Kanwar, Fnu Anamika, Inder Preet Kaur, Rohit Jain

Background: Geographical cohorting in hospital settings represents a significant shift from traditional patient rounding practices and aims to enhance the efficiency of health care delivery. This model assigns hospitalists to a particular inpatient unit, where most of their patients are located. While this model has several benefits, including streamlining health care procedures, optimizing resource allocation, and fostering better provider communication, its implementation is not without its challenges.

Methods: Our methodology for researching geographical cohorting involved a comprehensive literature review of peer-reviewed studies, surveys, and retrospective analyses. We utilized academic databases, such as PubMed, JSTOR, and Google Scholar, to identify relevant articles. Keywords used in the search included "geographic cohorting," "geographic rounding," "hospitalist," "patient outcomes," "provider satisfaction," and "hospital-acquired infections."

Conclusion: Geographical rounding has been associated with a reduction in the incidence of hospital-acquired infections and other adverse outcomes, suggesting its potential to create a safer patient care environment. However, problems such as increased interruptions, indirect care time, and the possibility of diminished interpersonal communication highlight the intricacy involved in successfully implementing such a model. The adoption of geographical cohorting is further complicated by operational problems, such as the necessity for major operational expenditure and patient flow management. Notwithstanding these difficulties, research has shown mixed results regarding geographic cohorting, with some studies suggesting potential advantages, such as enhanced interdisciplinary collaboration and a decline in provider burnout. However, its impact on patient outcomes, like in-patient stay and satisfaction, is inconsistent.

背景:医院环境中的地理队列代表了传统的患者围舍实践的重大转变,旨在提高卫生保健服务的效率。这种模式将医院医生分配到一个特定的住院病房,大多数病人都在那里。虽然这种模式有几个好处,包括简化医疗保健程序、优化资源分配和促进更好的提供者沟通,但其实施并非没有挑战。方法:我们研究地理队列的方法包括对同行评议研究、调查和回顾性分析的综合文献综述。我们利用PubMed、JSTOR和谷歌Scholar等学术数据库来识别相关文章。搜索中使用的关键词包括“地理队列”、“地理舍入”、“医院医生”、“患者结果”、“提供者满意度”和“医院获得性感染”。结论:地理围合与降低医院获得性感染和其他不良后果的发生率有关,表明它有可能创造一个更安全的患者护理环境。然而,诸如中断增加、间接护理时间和人际沟通减少的可能性等问题突出了成功实施这种模式所涉及的复杂性。由于业务方面的问题,例如需要大量业务支出和病人流量管理,采用地域分组进一步复杂化。尽管存在这些困难,但研究表明,地理队列的结果好坏参半,一些研究显示了潜在的优势,例如加强跨学科合作和减少提供者倦怠。然而,它对患者结果的影响,如住院时间和满意度,是不一致的。
{"title":"A New Paradigm in Hospital Medicine: Evaluating the Effects of Geographical Cohorting on Health Care Delivery.","authors":"Vasu Gupta, Bhupinder Singh, Kanishk Aggarwal, Ayushi Garg, Rhea Kanwar, Fnu Anamika, Inder Preet Kaur, Rohit Jain","doi":"10.36518/2689-0216.1865","DOIUrl":"10.36518/2689-0216.1865","url":null,"abstract":"<p><strong>Background: </strong>Geographical cohorting in hospital settings represents a significant shift from traditional patient rounding practices and aims to enhance the efficiency of health care delivery. This model assigns hospitalists to a particular inpatient unit, where most of their patients are located. While this model has several benefits, including streamlining health care procedures, optimizing resource allocation, and fostering better provider communication, its implementation is not without its challenges.</p><p><strong>Methods: </strong>Our methodology for researching geographical cohorting involved a comprehensive literature review of peer-reviewed studies, surveys, and retrospective analyses. We utilized academic databases, such as PubMed, JSTOR, and Google Scholar, to identify relevant articles. Keywords used in the search included \"geographic cohorting,\" \"geographic rounding,\" \"hospitalist,\" \"patient outcomes,\" \"provider satisfaction,\" and \"hospital-acquired infections.\"</p><p><strong>Conclusion: </strong>Geographical rounding has been associated with a reduction in the incidence of hospital-acquired infections and other adverse outcomes, suggesting its potential to create a safer patient care environment. However, problems such as increased interruptions, indirect care time, and the possibility of diminished interpersonal communication highlight the intricacy involved in successfully implementing such a model. The adoption of geographical cohorting is further complicated by operational problems, such as the necessity for major operational expenditure and patient flow management. Notwithstanding these difficulties, research has shown mixed results regarding geographic cohorting, with some studies suggesting potential advantages, such as enhanced interdisciplinary collaboration and a decline in provider burnout. However, its impact on patient outcomes, like in-patient stay and satisfaction, is inconsistent.</p>","PeriodicalId":73198,"journal":{"name":"HCA healthcare journal of medicine","volume":"6 1","pages":"23-30"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143607452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The "Wearing Off" Phenomenon for Rasagiline, Entacapone, Carbidopa, and Levodopa in the Setting of Parkinson's Disease. 罗沙吉兰、恩他卡彭、卡比多巴和左旋多巴在帕金森病中的“逐渐消失”现象
Pub Date : 2025-02-01 eCollection Date: 2025-01-01 DOI: 10.36518/2689-0216.1718
Ryan Cromwell, Tevin Um

Background: Parkinson's disease is a primary neurological dysfunction syndrome in which the body's natural production of dopamine is reduced. Therapeutic intervention for this disease primarily includes medications that increase the body's natural production of dopamine. These medications can have side effects, requiring constant titration based on the patient's symptoms.

Case presentation: We report a case study of a 75-year-old man diagnosed with Parkinson's disease who had a profound acute exacerbation of psychological symptoms following modifications to his dopaminergic treatment regimen. Initially, the patient was prescribed carbidopa/levodopa, rasagiline, and carbidopa/levodopa/entacapone. However, the treatment plan was adjusted due to the worsening of symptoms. The dose of carbidopa/levodopa was reduced, and rasagiline and Stalevo were stopped. Although the patient initially saw a temporary improvement, the patient later had hallucinations, delusions, agitation, dyskinesias, and akathisia. The laboratory testing and CT scan results showed no significant abnormalities.

Conclusion: This case highlights the importance of accurate dosage and vigilant supervision of Parkinson's disease medications' "wearing off" phenomenon. The patient's varying reaction to changes in medication and the subsequent appearance of psychiatric symptoms highlights the need for an individualized approach to managing Parkinson's disease. Collectively, these symptoms suggest that clinicians should consider the possibility of non-linear connections between dopaminergic therapy and symptom control. To effectively address the intricate relationship between motor symptoms and psychiatric manifestations, it is imperative to implement a multidisciplinary team approach in future management. This approach would involve closely monitoring and adapting treatment strategies.

背景:帕金森病是一种原发性神经功能障碍综合征,患者体内多巴胺的自然产生减少。这种疾病的治疗干预主要包括增加身体自然产生多巴胺的药物。这些药物可能有副作用,需要根据患者的症状不断滴定。病例介绍:我们报告了一个病例研究,一个75岁的男性诊断为帕金森病,他有一个深刻的急性加重心理症状后修改他的多巴胺能治疗方案。最初,患者开卡比多巴/左旋多巴、雷沙吉兰和卡比多巴/左旋多巴/恩他卡彭。但由于症状加重,调整了治疗方案。减少卡比多巴/左旋多巴剂量,停用雷沙吉兰和斯特列沃。虽然患者最初看到了暂时的改善,但患者后来出现了幻觉、妄想、躁动、运动障碍和静坐症。实验室检查和CT扫描结果未见明显异常。结论:本病例强调了准确剂量和警惕监督帕金森病药物“药效消失”现象的重要性。患者对药物变化的不同反应以及随后出现的精神症状突出了治疗帕金森病的个体化方法的必要性。总的来说,这些症状提示临床医生应该考虑多巴胺能治疗和症状控制之间的非线性联系的可能性。为了有效地解决运动症状与精神表现之间复杂的关系,在未来的治疗中必须实施多学科团队的方法。这种方法将涉及密切监测和调整治疗策略。
{"title":"The \"Wearing Off\" Phenomenon for Rasagiline, Entacapone, Carbidopa, and Levodopa in the Setting of Parkinson's Disease.","authors":"Ryan Cromwell, Tevin Um","doi":"10.36518/2689-0216.1718","DOIUrl":"10.36518/2689-0216.1718","url":null,"abstract":"<p><strong>Background: </strong>Parkinson's disease is a primary neurological dysfunction syndrome in which the body's natural production of dopamine is reduced. Therapeutic intervention for this disease primarily includes medications that increase the body's natural production of dopamine. These medications can have side effects, requiring constant titration based on the patient's symptoms.</p><p><strong>Case presentation: </strong>We report a case study of a 75-year-old man diagnosed with Parkinson's disease who had a profound acute exacerbation of psychological symptoms following modifications to his dopaminergic treatment regimen. Initially, the patient was prescribed carbidopa/levodopa, rasagiline, and carbidopa/levodopa/entacapone. However, the treatment plan was adjusted due to the worsening of symptoms. The dose of carbidopa/levodopa was reduced, and rasagiline and Stalevo were stopped. Although the patient initially saw a temporary improvement, the patient later had hallucinations, delusions, agitation, dyskinesias, and akathisia. The laboratory testing and CT scan results showed no significant abnormalities.</p><p><strong>Conclusion: </strong>This case highlights the importance of accurate dosage and vigilant supervision of Parkinson's disease medications' \"wearing off\" phenomenon. The patient's varying reaction to changes in medication and the subsequent appearance of psychiatric symptoms highlights the need for an individualized approach to managing Parkinson's disease. Collectively, these symptoms suggest that clinicians should consider the possibility of non-linear connections between dopaminergic therapy and symptom control. To effectively address the intricate relationship between motor symptoms and psychiatric manifestations, it is imperative to implement a multidisciplinary team approach in future management. This approach would involve closely monitoring and adapting treatment strategies.</p>","PeriodicalId":73198,"journal":{"name":"HCA healthcare journal of medicine","volume":"6 1","pages":"71-74"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143607206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Acknowledgement to the HCA Healthcare Journal of Medicine's Reviewers and Editors for the Second Half of 2024. 致《HCA 医疗保健医学杂志》2024 年下半年审稿人和编辑的感谢信。
Pub Date : 2025-02-01 eCollection Date: 2025-01-01 DOI: 10.36518/2689-0216.2196
Juan A Sanchez, Graig Donini

Description The HCA Healthcare Journal of Medicine would like to thank those behind the scenes who make this publication possible. Our journal would not be possible without the assistance of our peer reviewers, authors, and board members.

《HCA医疗保健医学杂志》要感谢那些使本出版物成为可能的幕后人员。如果没有同行审稿人、作者和董事会成员的帮助,我们的期刊是不可能成功的。
{"title":"An Acknowledgement to the <i>HCA Healthcare Journal of Medicine</i>'s Reviewers and Editors for the Second Half of 2024.","authors":"Juan A Sanchez, Graig Donini","doi":"10.36518/2689-0216.2196","DOIUrl":"https://doi.org/10.36518/2689-0216.2196","url":null,"abstract":"<p><p>Description The <i>HCA Healthcare Journal of Medicine</i> would like to thank those behind the scenes who make this publication possible. Our journal would not be possible without the assistance of our peer reviewers, authors, and board members.</p>","PeriodicalId":73198,"journal":{"name":"HCA healthcare journal of medicine","volume":"6 1","pages":"3-5"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892405/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143607459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthetic Versus Biologic Mesh for Complex Open Ventral Hernia Repair: 3-Year Follow-Up of a Pilot Randomized Controlled Trial. 合成补片与生物补片在复杂开放式腹疝修补中的对比:一项为期3年的随机对照试验。
Pub Date : 2025-02-01 eCollection Date: 2025-01-01 DOI: 10.36518/2689-0216.1761
Naila H Dhanani, Nicole B Lyons, Kyung Hyun Lee, Oscar A Olavarria, Aris R Arakelians, Julie L Holihan, Lillian S Kao, Ali Siddiqui, Connor Hogan, Tunmi Anwoju, Zuhair Ali, Mike K Liang

Background: Biologic mesh is often used in complex hernia repair, but there has been limited clinical evidence to date to support this practice. The aim of this study was to compare clinical and patient-reported outcomes of biologic versus synthetic mesh for complex open ventral hernia repair (OVHR) at 3 years.

Methods: Patients from a single center, randomized, controlled, pilot trial comparing biologic versus synthetic mesh in complex OVHR were followed for 3 years. The primary outcome focused on major complications, namely mesh infections, hernia recurrences, reoperations, and deaths. Secondary outcomes included surgical site infections, surgical site occurrences, and patient-reported outcomes. Outcomes were assessed using frequentist generalized linear models.

Results: A total of 87 patients (44 biologic mesh, 43 synthetic mesh) were randomized, and 61 patients (70%; 28 biologic and 33 synthetic) completed 3-year follow-up. Baseline demographics were similar in both groups. No significant differences were seen in major complications (50% vs 30%, P = .123), mesh infection (14% vs 3%, P = .144), recurrence (39% vs 24%, P = .214), reoperation (14% vs 9%, P = .531), or mortality (4% vs 0%, P = .459) between the 2 arms. A single death occurred as a result of bacteremia in a patient with hepatocellular carcinoma. Similarly, no significant differences were seen in secondary or patient-reported outcomes. Both groups demonstrated clinically important improvements in quality of life and pain scores at 3 years.

Conclusion: This study failed to find benefits with biologic mesh as opposed to synthetic mesh in complex OVHR at 3 years when comparing both clinical and patient-reported outcomes.

背景:生物补片常用于复杂疝修补,但迄今为止支持这种做法的临床证据有限。本研究的目的是比较生物补片与合成补片在复杂开放式腹疝修补术(OVHR)中3年的临床和患者报告的结果。方法:采用单中心、随机、对照、比较生物补片与合成补片治疗复杂OVHR的试验,对患者进行为期3年的随访。主要结果集中于主要并发症,即补片感染、疝复发、再手术和死亡。次要结局包括手术部位感染、手术部位发生和患者报告的结局。使用频率广义线性模型评估结果。结果:共纳入87例患者(生物补片44例,合成补片43例),61例患者(70%;生物制剂28例,合成制剂33例)完成3年随访。两组的基线人口统计数据相似。两组的主要并发症(50% vs 30%, P = 0.123)、补片感染(14% vs 3%, P = 0.144)、复发率(39% vs 24%, P = 0.214)、再手术(14% vs 9%, P = 0.531)或死亡率(4% vs 0%, P = 0.459)均无显著差异。一例肝细胞癌患者因菌血症死亡。同样,在次要或患者报告的结果中也没有发现显著差异。两组患者在3年时的生活质量和疼痛评分均有显著改善。结论:当比较临床和患者报告的结果时,该研究未能发现生物补片与合成补片在3年复杂OVHR中的益处。
{"title":"Synthetic Versus Biologic Mesh for Complex Open Ventral Hernia Repair: 3-Year Follow-Up of a Pilot Randomized Controlled Trial.","authors":"Naila H Dhanani, Nicole B Lyons, Kyung Hyun Lee, Oscar A Olavarria, Aris R Arakelians, Julie L Holihan, Lillian S Kao, Ali Siddiqui, Connor Hogan, Tunmi Anwoju, Zuhair Ali, Mike K Liang","doi":"10.36518/2689-0216.1761","DOIUrl":"10.36518/2689-0216.1761","url":null,"abstract":"<p><strong>Background: </strong>Biologic mesh is often used in complex hernia repair, but there has been limited clinical evidence to date to support this practice. The aim of this study was to compare clinical and patient-reported outcomes of biologic versus synthetic mesh for complex open ventral hernia repair (OVHR) at 3 years.</p><p><strong>Methods: </strong>Patients from a single center, randomized, controlled, pilot trial comparing biologic versus synthetic mesh in complex OVHR were followed for 3 years. The primary outcome focused on major complications, namely mesh infections, hernia recurrences, reoperations, and deaths. Secondary outcomes included surgical site infections, surgical site occurrences, and patient-reported outcomes. Outcomes were assessed using frequentist generalized linear models.</p><p><strong>Results: </strong>A total of 87 patients (44 biologic mesh, 43 synthetic mesh) were randomized, and 61 patients (70%; 28 biologic and 33 synthetic) completed 3-year follow-up. Baseline demographics were similar in both groups. No significant differences were seen in major complications (50% vs 30%, <i>P</i> = .123), mesh infection (14% vs 3%, <i>P</i> = .144), recurrence (39% vs 24%, <i>P</i> = .214), reoperation (14% vs 9%, <i>P</i> = .531), or mortality (4% vs 0%, <i>P</i> = .459) between the 2 arms. A single death occurred as a result of bacteremia in a patient with hepatocellular carcinoma. Similarly, no significant differences were seen in secondary or patient-reported outcomes. Both groups demonstrated clinically important improvements in quality of life and pain scores at 3 years.</p><p><strong>Conclusion: </strong>This study failed to find benefits with biologic mesh as opposed to synthetic mesh in complex OVHR at 3 years when comparing both clinical and patient-reported outcomes.</p>","PeriodicalId":73198,"journal":{"name":"HCA healthcare journal of medicine","volume":"6 1","pages":"43-50"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143607182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Unusual Presentation of Subcutaneous Inguinal Hematoma Mimicking Ovarian Torsion: A Case Report. 模仿卵巢扭转的腹股沟皮下血肿的异常表现:病例报告。
Pub Date : 2025-02-01 eCollection Date: 2025-01-01 DOI: 10.36518/2689-0216.1710
Chrystal Stallworth, Timothy Kremer, Victoria Panzanaro

Background: Ovarian or adnexal torsions occur when an ovary rotates around one of the supporting ligaments, often the infundibulopelvic (IP) ligament. This rotation can cause the blood flow to the ovary to be hindered, and this decrease in perfusion can often present as adnexal pain, nausea, and vomiting. A significant risk factor for developing an ovarian torsion is the presence of an ovarian mass, such as a cyst. The diagnosis of ovarian torsion is a medical emergency, but symptoms typically resolve with prompt surgical intervention. Hematomas occurring within or around the inguinal region have been reported to occur primarily after procedures such as ablations or inguinal hernia repairs. These hematomas commonly present post-operatively and are not typical features in the setting of adnexal torsion.

Case presentation: We report the case of a 36-year-old woman who presented with severe, acute-onset pelvic pain and prominent bruising on her left groin area following intercourse. A transvaginal ultrasound revealed the presence of a left ovarian cyst and lack of arterial blood flow to the left ovary, indicating the possibility of a left ovarian torsion. The patient underwent diagnostic laparoscopy with left oophorectomy. However, during the procedure an aberrant vessel was identified that branched from the left IP ligament, running through the inguinal canal, and terminated at the anterior abdominal wall. The vessel was ligated intraoperatively, and the patient ultimately recovered without complications. At the time of post-operative evaluation, the patient was without any recurring symptoms. This case report identifies an unusual presentation of symptoms mimicking ovarian torsion with accompanying ipsilateral subcutaneous inguinal hematoma secondary to aberrant pelvic vasculature.

Conclusion: Our patient had an unusual presentation of pelvic pain mimicking ovarian torsion with accompanying ipsilateral subcutaneous inguinal hematoma secondary to aberrant pelvic vasculature. According to our recent literature searches, there is no available clinical information regarding this combination presentation. The goal of this report is to provide insight into diagnosis and treatment for patients with this atypical presentation.

背景:卵巢或附件扭转发生在卵巢围绕支撑韧带之一旋转时,通常是骨盆底泡韧带(IP)。这种旋转会导致卵巢的血液流动受阻,血流灌注减少通常表现为附件疼痛、恶心和呕吐。发生卵巢扭转的一个重要危险因素是卵巢肿块的存在,如囊肿。卵巢扭转的诊断是一个医疗紧急情况,但症状通常解决与及时的手术干预。在腹股沟区域内或周围发生血肿主要发生在手术后,如消融或腹股沟疝修补。这些血肿通常出现在术后,并不是附件扭转的典型特征。病例介绍:我们报告的情况下,一个36岁的妇女谁提出了严重的,急性发作盆腔疼痛和突出瘀伤在她的左腹股沟区域性交。经阴道超声检查发现左卵巢囊肿,左卵巢动脉血流量不足,提示左卵巢扭转的可能性。患者行诊断性腹腔镜左卵巢切除术。然而,在手术过程中发现了一条异常血管,从左IP韧带分支,穿过腹股沟管,终止于前腹壁。术中结扎血管,患者最终康复,无并发症。术后评估时,患者无任何复发症状。本病例报告确定了一个不寻常的症状,模仿卵巢扭转,并伴有同侧皮下腹股沟血肿继发于异常盆腔血管。结论:我们的病人有一个不寻常的表现,骨盆疼痛模仿卵巢扭转,并伴有同侧皮下腹股沟血肿继发于异常盆腔血管。根据我们最近的文献检索,没有关于这种联合表现的可用临床信息。本报告的目的是为这种非典型表现的患者提供诊断和治疗的见解。
{"title":"An Unusual Presentation of Subcutaneous Inguinal Hematoma Mimicking Ovarian Torsion: A Case Report.","authors":"Chrystal Stallworth, Timothy Kremer, Victoria Panzanaro","doi":"10.36518/2689-0216.1710","DOIUrl":"10.36518/2689-0216.1710","url":null,"abstract":"<p><strong>Background: </strong>Ovarian or adnexal torsions occur when an ovary rotates around one of the supporting ligaments, often the infundibulopelvic (IP) ligament. This rotation can cause the blood flow to the ovary to be hindered, and this decrease in perfusion can often present as adnexal pain, nausea, and vomiting. A significant risk factor for developing an ovarian torsion is the presence of an ovarian mass, such as a cyst. The diagnosis of ovarian torsion is a medical emergency, but symptoms typically resolve with prompt surgical intervention. Hematomas occurring within or around the inguinal region have been reported to occur primarily after procedures such as ablations or inguinal hernia repairs. These hematomas commonly present post-operatively and are not typical features in the setting of adnexal torsion.</p><p><strong>Case presentation: </strong>We report the case of a 36-year-old woman who presented with severe, acute-onset pelvic pain and prominent bruising on her left groin area following intercourse. A transvaginal ultrasound revealed the presence of a left ovarian cyst and lack of arterial blood flow to the left ovary, indicating the possibility of a left ovarian torsion. The patient underwent diagnostic laparoscopy with left oophorectomy. However, during the procedure an aberrant vessel was identified that branched from the left IP ligament, running through the inguinal canal, and terminated at the anterior abdominal wall. The vessel was ligated intraoperatively, and the patient ultimately recovered without complications. At the time of post-operative evaluation, the patient was without any recurring symptoms. This case report identifies an unusual presentation of symptoms mimicking ovarian torsion with accompanying ipsilateral subcutaneous inguinal hematoma secondary to aberrant pelvic vasculature.</p><p><strong>Conclusion: </strong>Our patient had an unusual presentation of pelvic pain mimicking ovarian torsion with accompanying ipsilateral subcutaneous inguinal hematoma secondary to aberrant pelvic vasculature. According to our recent literature searches, there is no available clinical information regarding this combination presentation. The goal of this report is to provide insight into diagnosis and treatment for patients with this atypical presentation.</p>","PeriodicalId":73198,"journal":{"name":"HCA healthcare journal of medicine","volume":"6 1","pages":"65-70"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892400/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143607462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Terlipressin-Induced Hyponatremic Seizures in a Patient With Congenital Hepatic Fibrosis. 特利加压素诱发先天性肝纤维化患者的低钠血症发作。
Pub Date : 2025-02-01 eCollection Date: 2025-01-01 DOI: 10.36518/2689-0216.1806
Luca Gauci, Jorge Gafa, Suzanne Cauchi, Jurgen Gerada

Introduction: Acute variceal bleeding from portal hypertension is one of the most serious complications with a mortality rate of 15% to 25%. Terlipressin is a vasopressor that controls variceal bleeding by lowering the portal pressure and reducing blood flow to the varices.

Case presentation: We report a case of a patient with acute variceal bleeding, treated endoscopically and with terlipressin, who developed severe hyponatremia and seizures requiring admission to intensive care. Clinical and biochemical improvements were noticeable upon the cessation of terlipressin, with an eventual discharge from the hospital.

Conclusion: Prompt management of acute variceal bleeding with both endoscopic and medical interventions is required. Regular biochemical monitoring is necessary while a patient is on terlipressin treatment. The duration of treatment with terlipressin should not be prolonged unnecessarily.

门静脉高压引起的急性静脉曲张出血是最严重的并发症之一,死亡率为15%至25%。特利加压素是一种血管加压剂,通过降低门静脉压力和减少静脉曲张的血流量来控制静脉曲张出血。病例介绍:我们报告了一例急性静脉曲张出血的患者,经内窥镜和特利加压素治疗,出现严重的低钠血症和癫痫发作,需要入院重症监护。停止特利加压素后,临床和生化改善明显,最终出院。结论:急性静脉曲张出血的及时处理需要内窥镜和药物干预。在特利加压素治疗期间,定期进行生化监测是必要的。特利加压素治疗的时间不应不必要地延长。
{"title":"Terlipressin-Induced Hyponatremic Seizures in a Patient With Congenital Hepatic Fibrosis.","authors":"Luca Gauci, Jorge Gafa, Suzanne Cauchi, Jurgen Gerada","doi":"10.36518/2689-0216.1806","DOIUrl":"10.36518/2689-0216.1806","url":null,"abstract":"<p><strong>Introduction: </strong>Acute variceal bleeding from portal hypertension is one of the most serious complications with a mortality rate of 15% to 25%. Terlipressin is a vasopressor that controls variceal bleeding by lowering the portal pressure and reducing blood flow to the varices.</p><p><strong>Case presentation: </strong>We report a case of a patient with acute variceal bleeding, treated endoscopically and with terlipressin, who developed severe hyponatremia and seizures requiring admission to intensive care. Clinical and biochemical improvements were noticeable upon the cessation of terlipressin, with an eventual discharge from the hospital.</p><p><strong>Conclusion: </strong>Prompt management of acute variceal bleeding with both endoscopic and medical interventions is required. Regular biochemical monitoring is necessary while a patient is on terlipressin treatment. The duration of treatment with terlipressin should not be prolonged unnecessarily.</p>","PeriodicalId":73198,"journal":{"name":"HCA healthcare journal of medicine","volume":"6 1","pages":"83-87"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143607189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
HCA healthcare journal of medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1